David Rhyne
Internal Medicine · Enterprise, ALNPI 1285627109
Payments from drug & device makers
Across 341 payments — averaging $12.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$642
- GSK$510
- Johnson & Johnson$500
- AstraZeneca$409
- Pfizer$273
- Novartis$235
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,347100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $642 |
| GSK | 40 | $510 |
| Johnson & Johnson | 38 | $500 |
| AstraZeneca | 28 | $409 |
| Pfizer | 25 | $273 |
| Novartis | 21 | $235 |
| Amarin Pharma, Inc. | 12 | $218 |
| Corcept Therapeutics | 8 | $186 |
| Boehringer Ingelheim | 15 | $176 |
| Amgen | 16 | $155 |
| Novo Nordisk | 8 | $124 |
| Lilly USA, LLC | 16 | $119 |
| Merck | 15 | $115 |
| Esperion Therapeutics, Inc. | 5 | $99 |
| Biohaven Pharmaceuticals, Inc. | 4 | $90 |
| Ironwood Pharmaceuticals, Inc | 7 | $82 |
| Nestle Healthcare Nutrition Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $53 |
| Mylan Specialty L.p. | 3 | $51 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| Eisai Inc. | 2 | $30 |
| Emmaus Medical, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
| Shire North American Group Inc | 1 | $11 |
| Hologic Sales And Service, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOKANA$109
How this compares
$4,366 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,804 |
| JanuviaSitagliptin Phosphate | 12 | $7,497 |
| Fluorometholone | 21 | $1,682 |
| Potassium Chloride | 16 | $1,336 |
| Diclofenac Sodium | 20 | $861 |
| Levothyroxine Sodium | 36 | $653 |
| Pantoprazole Sodium | 41 | $555 |
| Flecainide Acetate | 12 | $460 |
| Amlodipine Besylate | 35 | $329 |
| Atorvastatin Calcium | 12 | $296 |
| Lisinopril | 29 | $274 |
| ClopidogrelClopidogrel Bisulfate | 12 | $250 |
| Donepezil Hcl | 11 | $246 |
| Levocetirizine Dihydrochloride | 12 | $240 |
| Furosemide | 12 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $273 | $7,80412 claims |
| MerckJanuvia | $115 | $7,49712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,533 internal medicine providers in Alabama.
Other internal medicine in Enterprise
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- Barry McLeanHomewood$4M
- William KirbyBirmingham$2.3M
- Saadat AnsariHuntsville$2.1M
- Gregory FlippoTrussville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.